SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Raises Price Target to $28

HC Wainwright & Co. reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and raises the price target from $25 to $28.

Benzinga · 05/11/2020 11:44

HC Wainwright & Co. reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and raises the price target from $25 to $28.